Donation opens new opportunities for more effective diabetes treatment
Karolinska Institutet has received a grant of 1.6 million Euro from the Stichting af Jochnick Foundation for research into the fundamental causes of diabetes. The grant will make it possible to use unique methods to study how the release of insulin is regulated in living organisms - and this will create new opportunities for developing more effective drugs against diabetes.
Diabetes is an extremely common condition, and the number of people affected is increasing catastrophically all over the world. It has been calculated that in 2025, 300 million people will suffer from the disease, which not only causes major personal difficulties, but also places an enormous economic burden on the healthcare system. Professor Per-Olof Berggren at Karolinska Institutet has worked for many years mapping the signalling systems that regulate the release of insulin, and his research has led to several revolutionary discoveries.
"Diabetes is a global problem, and this means that it is vital that we understand the causes of the disease, in order to be able to offer more effective treatment. This is why we find it particularly important to support Professor Berggren's innovative and creative research", says Robert af Jochnick, who established the Jochnick Foundation together with his brother Jonas.
